Latest Market News

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.

Star Minerals Limited has voluntarily suspended trading on the ASX pending an important announcement related to assay results and a price query. The suspension is expected to last until 20 August or until the announcement is released.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

Adrad Holdings reported an 8.9% rise in FY25 sales revenue to $153.1 million despite a slight dip in EBITDA, while declaring a fully franked dividend and outlining strategic initiatives for FY26.

Mount Hope Mining (MHM) has initiated its maiden drilling campaign targeting gold and base metals in the prolific southern Cobar Basin, aiming to define a JORC resource and accelerate development.

Kinetiko Energy reports a peak gas flow rate of 370 Mscfd from its optimised drilling at the Brakfontein well 271-KA03PT10, advancing its South African gas project.

360 Capital REIT has reported a significant turnaround with a $1.3 million statutory profit for FY25, alongside reduced distributions and a new long-term investment management agreement. The fund’s portfolio remains stable, supported by improved leasing and ESG upgrades.

Lendlease Group has announced a fully franked ordinary dividend of AUD 0.1696 per security for the first half of FY25, alongside a Dividend Reinvestment Plan with no discount.

betr Entertainment has officially launched its all-scrip takeover offer for PointsBet shareholders, valuing shares above a rival cash bid and promising significant cost synergies.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

Apiam Animal Health has received a non-binding indicative proposal from Adamantem Capital Management to acquire the company at $0.88 per share, sparking a potential shift in ownership for the veterinary services leader.